isirv antiviral
@isirvAVG
Followers
529
Following
16
Media
413
Statuses
5K
#Antiviral focus group of the International Society for #Influenza & other Respiratory Virus Diseases (isirv). Lida DeSouza: Secretariat
UK
Joined April 2012
If you missed the ISIRV webinar on 29 May on ‘Recent antiviral developments for respiratory viral infections’, you can watch the recording via this link:
0
3
5
Register for the next ISIRV webinar on 5 Nov at 13:00 GMT (08:00 EST) on 'Highlights from OPTIONS for the Control of Influenza XII'. @K_RenfreeShort will give the Keynote Talk on Scientific Insights from the meeting.
0
4
3
To the avian flu community, this could be of interest:.The 11th occurrence of the International Symposium on Avian Flu will take place 24-25 June 2025 in St. John’s, Newfoundland, Canada. @DuckSwabber.
0
6
7
Still time to register for the isirv-AVG webinar on 'New Treatments for Respiratory Viruses' on 29 May - Keynote Speaker - Pro Bin Cao, Beijing, China.Additional speakers are @TomFletcherlstm and Don Ganem
0
1
3
The next ISIRV webinar on 'New Treatments for Respiratory Viruses' is on 29 May. Prof Bin Cao from Beijing will speak on 'Overview of the Recent Antiviral Developments for Respiratory Viral Infections in China'. Register today -
0
3
3
RT @Fla_Medic: AFD Blog `Vietnam #MOH Statement: Epidemiological Investigation Into Human #H5N1 Infection'
0
2
0
It's not too late to register for our next ISIRV webinar on 20 March. @Rafael_AMedina will speak on 'Overview on Emerging Influenza Threats and Response' .Register today
0
0
1
RT @Fla_Medic: AFD Blog `Transboundary & Emerg. Dis.: H3 Avian Influenza Virus Isolated from China in 2021–2022 Showed the Emerging #H3N8 P….
0
2
0
RT @JeremyFarrar: With this & other advances in technology the science & the terms “vaccine” and “therapeutic” will increasingly blurr with….
0
1
0
All Hands on Deck at Pfizer as Scientists Revive SARS Protease Inhibitor to Attempt to Fight COVID-19.
0
0
0
Shionogi reports data from Phase III portion of Covid-19 drug trial
clinicaltrialsarena.com
Shionogi announced that ensitrelvir, a Covid-19 drug, met primary and secondary endpoints in the Phase III segment of SCORPIO-SR study.
0
0
0
Rutgers researchers work on breakthrough COVID-19 treatment.
njspotlightnews.org
Interview: Dr. Jun Wang, lead researcher
0
0
0
Outcomes of Pediatric SARS-CoV-2 Omicron Infection vs Influenza and Respiratory Syncytial Virus Infections
0
1
4
Our next ISIRV webinar on 'Emerging Influenza and the Human-Animal Interface' will be on 20 March - register today
0
1
0
Come and join us for our next AVG Webinar on Surveillance, Tuesday 20 June at 8.30am ET; 1.30pm BST; 2.30pm CET & 9.30pm CST. Register today:
0
0
1
The 7th AVG in-person Conference is just over a month away! You can still register. There are a limited number of bedrooms at the conference hotel still available - book by 7 April to get the special rate. See you in Seattle!.
0
1
2
B cells vs T cells - new study reveals which are first responders against breakthrough #COVID infection .@MariosKoutsakos @scientist_JJ @viralvaxlab @UniMelbMDHS @TheRMH.
0
0
0
Interferon Lambda, a Potential New #COVID-19 Treatment.
self.com
Interferon lambda, an injectable drug in development, is already being compared to Paxlovid.
0
1
0